Literature DB >> 17038080

Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Carolyn W Zhu1, Nikolaos Scarmeas, Rebecca Torgan, Marilyn Albert, Jason Brandt, Deborah Blacker, Mary Sano, Yaakov Stern.   

Abstract

Most estimates of the cost of informal caregiving in patients with Alzheimer's disease (AD) remain cross-sectional. Longitudinal estimates of informal caregiving hours and costs are less frequent and are from assessments covering only short periods of time. The objectives of this study were to estimate long-term trajectories of the use and cost of informal caregiving for patients with AD and the effects of patient characteristics on the use and cost of informal caregiving. The sample is drawn from the Predictors Study, a large, multicenter cohort of patients with probable AD, prospectively followed annually for up to 7 years in three university-based AD centers in the United States (n=170). Generalized linear mixed models were used to estimate the effects of patient characteristics on use and cost of informal caregiving. Patients' clinical characteristics included cognitive status (Mini-Mental State Examination), functional capacity (Blessed Dementia Rating Scale (BDRS)), comorbidities, psychotic symptoms, behavioral problems, depressive symptoms, and extrapyramidal signs. Results show that rates of informal care use and caregiving hours (and costs) increased substantially over time but were related differently to patients' characteristics. Use of informal care was significantly associated with worse cognition, worse function, and higher comorbidities. Conditional on receiving informal care, informal caregiving hours (and costs) were mainly associated with worse function. Each additional point on the BDRS increased informal caregiving costs 5.4%. Average annual informal cost was estimated at $25,381 per patient, increasing from $20,589 at baseline to $43,030 in Year 4.

Entities:  

Mesh:

Year:  2006        PMID: 17038080      PMCID: PMC3229197          DOI: 10.1111/j.1532-5415.2006.00871.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  24 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The incremental direct costs associated with behavioral symptoms in AD.

Authors:  D L Murman; Q Chen; M C Powell; S B Kuo; C J Bradley; C C Colenda
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

3.  Cost of illness of Alzheimer's disease: how useful are current estimates?

Authors:  Bernard S Bloom; Nathalie de Pouvourville; Walter L Straus
Journal:  Gerontologist       Date:  2003-04

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Clinical features associated with costs in early AD: baseline data from the Predictors Study.

Authors:  C W Zhu; N Scarmeas; R Torgan; M Albert; J Brandt; D Blacker; M Sano; Y Stern
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

7.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.

Authors:  N Scarmeas; J Brandt; M Albert; D P Devanand; K Marder; K Bell; A Ciappa; B Tycko; Y Stern
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

8.  The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies.

Authors:  Daniel L Murman; Sherry B Kuo; Michelle C Powell; Christopher C Colenda
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

9.  Ethnic differences in the prevalence and pattern of dementia-related behaviors.

Authors:  Kaycee M Sink; Kenneth E Covinsky; Robert Newcomer; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2004-08       Impact factor: 5.562

10.  Motor signs during the course of Alzheimer disease.

Authors:  N Scarmeas; G M Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; J Brandt; M Albert; K Marder; K Bell; L S Honig; D Wegesin; Y Stern
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

View more
  31 in total

1.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

Review 2.  A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.

Authors:  Mark Oremus; S Carolina Aguilar
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

3.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

Authors:  Maurice W Dysken; Mary Sano; Sanjay Asthana; Julia E Vertrees; Muralidhar Pallaki; Maria Llorente; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Sally Zachariah; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Yoav Segal; Peter N Peduzzi; Peter D Guarino
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

4.  Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.

Authors:  Ansgar Wübker; Sandra M G Zwakhalen; David Challis; Riitta Suhonen; Staffan Karlsson; Adelaida Zabalegui; Maria Soto; Kai Saks; Dirk Sauerland
Journal:  Eur J Health Econ       Date:  2014-07-29

5.  Disease progression and costs of care in Alzheimer's disease patients treated with donepezil: a longitudinal naturalistic cohort.

Authors:  Anders Gustavsson; Linus Jönsson; Johan Parmler; Niels Andreasen; Carina Wattmo; Åsa K Wallin; Lennart Minthon
Journal:  Eur J Health Econ       Date:  2011-08-06

6.  Testing Tele-Savvy: Protocol for a randomized controlled trial.

Authors:  Mariya A Kovaleva; Elizabeth Bilsborough; Patricia C Griffiths; Joe Nocera; Melinda Higgins; Fayron Epps; Katie Kilgore; Allison Lindauer; Darby Morhardt; Raj C Shah; Kenneth Hepburn
Journal:  Res Nurs Health       Date:  2018-02-05       Impact factor: 2.228

7.  Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.

Authors:  Stephanie Behrens; Gail B Rattinger; Sarah Schwartz; Joshua Matyi; Chelsea Sanders; M Scott DeBerard; Constantine G Lyketsos; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2018-03-21       Impact factor: 3.878

8.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

9.  Longitudinal predictors of informal and formal caregiving time in community-dwelling dementia patients.

Authors:  André Hajek; Christian Brettschneider; Annette Ernst; Tina Posselt; Birgitt Wiese; Jana Prokein; Siegfried Weyerer; Jochen Werle; Angela Fuchs; Michael Pentzek; Janine Stein; Steffi G Riedel-Heller; Horst Bickel; Edelgard Mösch; Kathrin Heser; Frank Jessen; Wolfgang Maier; Martin Scherer; Hans-Helmut König
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-10-23       Impact factor: 4.328

10.  Relationships among disordered sleep and cognitive and functional status in nursing home residents.

Authors:  Catherine S Cole; Kathy C Richards; Cornelia C Beck; Paula K Roberson; Corinne Lambert; Allison Furnish; Jon Free; Joan Tackett
Journal:  Res Gerontol Nurs       Date:  2009-06-30       Impact factor: 1.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.